{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:25:57Z","timestamp":1790774757470,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ijcard.2022.05.024","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T11:15:25Z","timestamp":1652440525000},"page":"20-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Bioresorbable stents: Is the game over?"],"prefix":"10.1016","volume":"361","author":[{"given":"Emanuele","family":"Gallinoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Almendarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rut","family":"Alvarez-Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Avanzas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2022.05.024_bb0005","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMra1210816","article-title":"Drug-eluting coronary-artery stents","volume":"368","author":"Stefanini","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0010","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM200104123441502","article-title":"Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease","volume":"344","author":"Serruys","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0015","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007023","article-title":"Restenosis of drug-eluting stents: a new classification system based on disease mechanism to guide treatment and state-of-the-art review","volume":"12","author":"Shlofmitz","year":"2019","journal-title":"Circ. Cardiovasc. Interv"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/17434440.2021.1904894","article-title":"Current perspectives on bioresorbable scaffolds in coronary intervention and other fields","volume":"18","author":"Wu","year":"2021","journal-title":"Exp. Rev. Med. Devic."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.15420\/icr.2014.9.3.175","article-title":"Bioresorbable scaffolds","volume":"9","author":"Panaich","year":"2014","journal-title":"Interv. Cardiol."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0030","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/CIRCULATIONAHA.110.971606","article-title":"Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?","volume":"123","author":"Onuma","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0035","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa1614954","article-title":"Bioresorbable scaffolds versus metallic stents in routine PCI","volume":"376","author":"Wykrzykowska","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0040","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/S0140-6736(16)32050-5","article-title":"Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial","volume":"388","author":"Serruys","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fbioe.2019.00259","article-title":"A perspective on polylactic acid-based polymers use for nanoparticles synthesis and applications","volume":"7","author":"Casalini","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jbm.b.33794","article-title":"Drug loaded nanoparticle coating on totally bioresorbable PLLA stents to prevent in-stent restenosis","volume":"106","author":"Zhao","year":"2018","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0055","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jcin.2013.05.017","article-title":"Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort a trial","volume":"6","author":"Onuma","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0060","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jacc.2015.11.060","article-title":"A polylactide bioresorbable scaffold eluting everolimus for treatment of coronary stenosis: 5-year follow-up","volume":"67","author":"Serruys","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","volume":"385","author":"Serruys","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0070","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-eluting bioresorbable scaffolds for coronary artery disease","volume":"373","author":"Ellis","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0075","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.jacc.2015.09.054","article-title":"Bioresorbable vascular scaffolds versus metallic stents in patients with coronary artery disease: ABSORB China trial","volume":"66","author":"Gao","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0080","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1093\/eurheartj\/ehv435","article-title":"A randomized trial evaluating everolimus-eluting absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan","volume":"36","author":"Kimura","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0085","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jacc.2014.12.017","article-title":"Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds","volume":"65","author":"Puricel","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0090","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(17)31470-8","article-title":"2-year outcomes with the absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy","volume":"390","author":"Ali","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0095","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/CIRCULATIONAHA.117.031843","article-title":"Three-year outcomes with the absorb Bioresorbable scaffold: individual-patient-data Meta-analysis from the ABSORB randomized trials","volume":"137","author":"Ali","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0100","first-page":"E1","article-title":"Three-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds: final results of the ABSORB EXTEND trial","volume":"93","author":"Costa","year":"2019","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0105","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.carrev.2019.07.018","article-title":"Outcomes of optimised implantation technique with Bioresorbable scaffolds: a pooled analysis of ABSORB-IV and COMPARE-ABSORB trials","volume":"21","author":"Danzi","year":"2020","journal-title":"Cardiovasc. Revasc. Med."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0110","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.4244\/EIJV12I10A209","article-title":"Clinical and multimodality imaging results at 6 months of a bioresorbable sirolimus-eluting scaffold for patients with single de novo coronary artery lesions: the NeoVas first-in-man trial","volume":"12","author":"Zhang","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0115","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jcin.2017.09.037","article-title":"A randomized trial comparing the NeoVas Sirolimus-eluting Bioresorbable scaffold and metallic Everolimus-eluting stents","volume":"11","author":"Han","year":"2018","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0120","first-page":"832","article-title":"Safety and efficacy of the novel sirolimus-eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: one-year results from a prospective patient-level pooled analysis of NeoVas trials","volume":"93","author":"Xu","year":"2019","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0125","doi-asserted-by":"crossref","first-page":"828","DOI":"10.4244\/EIJV12I7A137","article-title":"Magmaris preliminary recommendation upon commercial launch: a consensus from the expert panel on 14 April 2016","volume":"12","author":"Fajadet","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.carrev.2021.02.003","article-title":"SICI-GISE position document on the use of the Magmaris Resorbable magnesium scaffold in clinical practice","volume":"34","author":"Galli","year":"2022","journal-title":"Cardiovasc. Revasc. Med."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0135","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)00447-X","article-title":"Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial","volume":"387","author":"Haude","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0140","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.carrev.2020.04.006","article-title":"Sustained safety and performance of the second-generation Sirolimus-eluting absorbable metal scaffold: pooled outcomes of the BIOSOLVE-II and -III trials at 3 years","volume":"21","author":"Haude","year":"2020","journal-title":"Cardiovasc. Revasc. Med."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0145","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/CIRCULATIONAHA.119.043467","article-title":"Magnesium-based resorbable scaffold versus permanent metallic Sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: the MAGSTEMI randomized clinical trial","volume":"140","author":"Sabat\u00e9","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0150","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.4244\/EIJY14M07_11","article-title":"Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry","volume":"10","author":"Capodanno","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0155","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.4244\/EIJY14M08_08","article-title":"Initial experience and clinical evaluation of the absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC single Centre real world PCI registry","volume":"10","author":"Kraak","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0160","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.4244\/EIJ-D-21-00419","article-title":"Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial","volume":"17","author":"Kerkmeijer","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0165","doi-asserted-by":"crossref","first-page":"V175","DOI":"10.4244\/EIJV11SVA42","article-title":"Treatment of bioresorbable scaffold failure","volume":"11 Suppl V","author":"Felix","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0170","doi-asserted-by":"crossref","DOI":"10.1115\/1.4053503","article-title":"Coronary artery stenting Affects Wall shear stress topological skeleton","volume":"144","author":"Chiastra","year":"2022","journal-title":"J. Biomech. Eng."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0175","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.atherosclerosis.2021.11.010","article-title":"Risk of myocardial infarction based on endothelial shear stress analysis using coronary angiography","volume":"342","author":"Candreva","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0180","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jacc.2015.08.853","article-title":"Very late scaffold thrombosis: intracoronary imaging and histopathological and spectroscopic findings","volume":"66","author":"R\u00e4ber","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2022.05.024_bb0185","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5603\/CJ.a2022.0001","article-title":"The role of superficial wall stress and mechanical factors in scaffold failure: protocol of the RANSOMED study","volume":"29","author":"Guti\u00e9rrez-Chico","year":"2022","journal-title":"Cardiol. J."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0190","first-page":"444","article-title":"Clinical outcomes of patients with diabetes mellitus treated with absorb bioresorbable vascular scaffolds: a subanalysis of the European multicentre GHOST-EU registry","volume":"91","author":"Capranzano","year":"2018","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.765071","article-title":"Microvascular dysfunction in patients with type II diabetes mellitus: invasive assessment of absolute coronary blood flow and microvascular resistance reserve","volume":"8","author":"Gallinoro","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0200","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4244\/EIJV9I1A10","article-title":"Incidence and predictors of stent thrombosis: a single-Centre study of 5,833 consecutive patients undergoing coronary artery stenting","volume":"9","author":"Iqbal","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0205","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2008.12.055","article-title":"Predictors of coronary stent thrombosis: the Dutch stent thrombosis registry","volume":"53","author":"van Werkum","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0210","doi-asserted-by":"crossref","first-page":"e981","DOI":"10.4244\/EIJ-D-21-00263","article-title":"Optimal dual antiplatelet therapy duration for bioresorbable scaffolds: an individual patient data pooled analysis of the ABSORB trials","volume":"17","author":"Azzalini","year":"2021","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0215","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.4244\/EIJ-D-18-00295","article-title":"Pre-infarction angina and culprit lesion morphologies in patients with a first ST-segment elevation acute myocardial infarction: insights from in vivo optical coherence tomography","volume":"14","author":"Sun","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0220","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jcin.2014.10.005","volume":"8","author":"Brugaletta","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0225","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.4244\/EIJ-D-18-01080","article-title":"Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents: a pooled analysis of individual patient data","volume":"15","author":"Cassese","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0230","doi-asserted-by":"crossref","DOI":"10.4244\/EIJ-D-21-00651","article-title":"Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial","author":"Ortega-Paz","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0235","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1016\/j.jacc.2017.10.010","article-title":"3-year clinical outcomes with Everolimus-eluting Bioresorbable coronary scaffolds: the ABSORB III trial","volume":"70","author":"Kereiakes","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0240","article-title":"Bioresorbable magnesium scaffold in the treatment of simple coronary bifurcation lesions: the BIFSORB pilot II study","author":"Barkholt","year":"2021","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0245","doi-asserted-by":"crossref","first-page":"V188","DOI":"10.4244\/EIJV11SVA45","article-title":"The future of BRS in bifurcations","volume":"11 Suppl V","author":"Kraak","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0250","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2022.01.066","article-title":"Physiological and angiographic outcomes of PCI in calcified lesions after rotational atherectomy or intravascular lithotripsy","volume":"352","author":"Gallinoro","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0255","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.4244\/EIJY15M03_11","article-title":"Procedural outcomes of patients with calcified lesions treated with bioresorbable vascular scaffolds","volume":"11","author":"Panoulas","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0260","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.4244\/EIJ-D-16-00974","article-title":"Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score","volume":"12","author":"Ortega-Paz","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0265","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10554-011-9829-y","article-title":"Quantitative multi-modality imaging analysis of a fully bioresorbable stent: a head-to-head comparison between QCA, IVUS and OCT","volume":"28","author":"Guti\u00e9rrez-Chico","year":"2012","journal-title":"Int. J. Card. Imaging"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0270","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ijcard.2016.07.033","article-title":"Optical coherence tomography guidance for percutaneous coronary intervention with bioresorbable scaffolds","volume":"221","author":"Caiazzo","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0275","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0280","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0285","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/eurheartj\/ehy710","volume":"40","author":"Byrne","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0290","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.4244\/EIJ-D-21-00653","article-title":"Clinical outcomes of everolimus-eluting bioresorbable scaffolds or everolimus-eluting stents in patients with acute myocardial infarction: two-year results of the randomised ISAR-absorb MI trial","volume":"17","author":"Wiebe","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0295","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jcin.2016.12.279","article-title":"Antiplatelet therapy after implantation of Bioresorbable vascular scaffolds: a review of the published data, practical recommendations, and future directions","volume":"10","author":"Capodanno","year":"2017","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0300","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4244\/EIJY15M01_05","article-title":"Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective","volume":"11","author":"Tamburino","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0305","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2174\/1570161117666190513105859","article-title":"Antiplatelet therapy in acute coronary syndromes. Lights and shadows of platelet function tests to guide the best therapeutic approach","volume":"18","author":"Cimmino","year":"2020","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0310","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11239-019-01811-2","article-title":"Guided de-escalation of DAPT in acute coronary syndrome patients undergoing percutaneous coronary intervention with BVS implantation: a post-hoc analysis from the randomized TROPICAL-ACS trial","volume":"47","author":"Koltowski","year":"2019","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0315","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.4244\/EIJ-D-19-00600","article-title":"First-in-human evaluation of a novel sirolimus-eluting ultra-high molecular weight APTITUDE bioresorbable scaffold: 9- and 24-month imaging and clinical results of the RENASCENT II trial","volume":"16","author":"Chieffo","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0320","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/09205063.2019.1586303","article-title":"Mechanical properties and degradation of drug eluted bioresorbable vascular scaffolds prepared by three-dimensional printing technology","volume":"30","author":"Zhang","year":"2019","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0325","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.21037\/atm-20-6739","article-title":"Three-year clinical outcomes of a sirolimus-eluting bioresorbable scaffold (XINSORB) and a metallic stent to treat coronary artery stenosis","volume":"8","author":"Wu","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2022.05.024_bb0330","first-page":"648","article-title":"First-in-man study of a thinner-strut sirolimus-eluting bioresorbable scaffold (FUTURE-I): three-year clinical and imaging outcomes","volume":"95","author":"Song","year":"2020","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0335","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.jcin.2021.04.048","article-title":"Thinner strut Sirolimus-eluting BRS versus EES in patients with coronary artery disease: FUTURE-II trial","volume":"14","author":"Song","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0340","first-page":"1084","article-title":"Hemodynamic analysis of a novel bioresorbable scaffold in porcine coronary artery model","volume":"91","author":"Tenekecioglu","year":"2018","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0345","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jcin.2017.03.015","article-title":"Randomized comparison of absorb Bioresorbable vascular scaffold and Mirage microfiber Sirolimus-eluting scaffold using multimodality imaging","volume":"10","author":"Tenekecioglu","year":"2017","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0350","doi-asserted-by":"crossref","first-page":"B158","DOI":"10.1016\/j.jacc.2018.08.1549","article-title":"TCT-392 a first-in-man study of the bioheart Sirolimus-eluting Bioresorbable scaffold in patients with coronary artery disease: one-year clinical and imaging outcomes","volume":"72","author":"Guan","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0355","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jamacardio.2019.4101","article-title":"Time-varying outcomes with the absorb Bioresorbable vascular scaffold during 5-year follow-up: a systematic Meta-analysis and individual patient data pooled study","volume":"4","author":"Stone","year":"2019","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2022.05.024_bb0360","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/CIRCINTERVENTIONS.113.000990","article-title":"Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery model","volume":"7","author":"Otsuka","year":"2014","journal-title":"Circ. Cardiovasc. Interv"},{"key":"10.1016\/j.ijcard.2022.05.024_bb0365","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1161\/CIRCULATIONAHA.109.921528","volume":"122","author":"Onuma","year":"2010","journal-title":"Circulation"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527322007331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527322007331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:58:10Z","timestamp":1759093090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527322007331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":73,"alternative-id":["S0167527322007331"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2022.05.024","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioresorbable stents: Is the game over?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2022.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}